statementSaid on 2026-11-11
港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。
A statement by post author, said on 2026-11-11. Statements are as reported by the cited publishers — not verified by DecisionGateway.
港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗
Discussion
Related claims
此舉令香港成為亞洲首個推行組織碎化技術(Histotripsy)腎臟癌臨床試驗的城市。李嘉誠基金會 · statement港怡自今年3月31日開始,已成功完成20宗胰臟腫瘤個案。post author · statementHong Kong has launched Asia's first kidney cancer clinical trial.headline · statement李嘉誠將向香港中文大學醫院、港怡醫院及養和醫院提供30個臨床試驗名額。李嘉誠基金會 · commitment截至目前,累計與43國的48家醫院建立對口合作關係,共同開展聯合科研和臨牀試驗。梁林沖 · statementTigermed announced it will participate in the privatization and business split of Frontage Holdings through its wholly-owned subsidiary Hong Kong Tigermed.瑞銀 · statement